Yorktown Management & Research Company’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,753
Closed -$265K 237
2023
Q4
$265K Hold
5,753
0.28% 190
2023
Q3
$247K Hold
5,753
0.28% 195
2023
Q2
$275K Hold
5,753
0.3% 165
2023
Q1
$280K Hold
5,753
0.3% 147
2022
Q4
$304K Hold
5,753
0.37% 135
2022
Q3
$252K Buy
+5,753
New +$284K 0.33% 138

Other funds holding QGEN

Yorktown Management & Research Company's QGEN Position: Q1 2024 in Review

Yorktown Management & Research Company sold out of Qiagen (QGEN) in Q1 2024, closing a stake of 5,753 shares — an estimated $265K sold.

Yorktown Management & Research Company first reported a position in QGEN in Q3 2022 and held it in 6 quarters. The position peaked at $304K in Q4 2022. 283 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

  • Yorktown Management & Research Company reported no remaining Qiagen position as of Q1 2024 after selling out during the quarter.
  • Yorktown Management & Research Company sold 5,753 Qiagen shares in Q1 2024, an estimated $265K.
  • Yorktown Management & Research Company first reported a position in Qiagen in Q3 2022 and held it in 6 quarters.
  • Yorktown Management & Research Company's Qiagen position peaked at $304K in Q4 2022.
  • 283 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Yorktown Management & Research Company's 13F filing for Q1 2024, filed 26 Apr 2024.